AdvanSix (NYSE:ASIX) Stock Rating Lowered by Wall Street Zen
by Teresa Graham · The Cerbat GemAdvanSix (NYSE:ASIX – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Friday.
A number of other research firms also recently weighed in on ASIX. Weiss Ratings reissued a “sell (d+)” rating on shares of AdvanSix in a research note on Monday, December 29th. Truist Financial assumed coverage on AdvanSix in a research note on Thursday, January 15th. They issued a “hold” rating and a $19.00 target price on the stock. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $28.67.
Read Our Latest Analysis on ASIX
AdvanSix Trading Down 0.3%
Shares of NYSE ASIX traded down $0.04 during mid-day trading on Friday, hitting $17.06. The company’s stock had a trading volume of 323,953 shares, compared to its average volume of 318,540. AdvanSix has a one year low of $14.10 and a one year high of $32.58. The company’s fifty day simple moving average is $16.46 and its 200-day simple moving average is $18.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.36 and a quick ratio of 0.74. The stock has a market cap of $458.12 million, a price-to-earnings ratio of 8.88 and a beta of 1.71.
AdvanSix (NYSE:ASIX – Get Free Report) last posted its quarterly earnings results on Friday, November 7th. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.32). AdvanSix had a return on equity of 7.14% and a net margin of 3.52%.The business had revenue of $374.47 million for the quarter, compared to the consensus estimate of $365.00 million. On average, sell-side analysts anticipate that AdvanSix will post 4 earnings per share for the current fiscal year.
Institutional Investors Weigh In On AdvanSix
Several large investors have recently modified their holdings of the business. Deprince Race & Zollo Inc. increased its stake in AdvanSix by 15.1% during the 4th quarter. Deprince Race & Zollo Inc. now owns 293,768 shares of the company’s stock worth $5,082,000 after purchasing an additional 38,611 shares in the last quarter. Sheets Smith Wealth Management lifted its stake in AdvanSix by 3.8% in the fourth quarter. Sheets Smith Wealth Management now owns 17,878 shares of the company’s stock valued at $309,000 after buying an additional 659 shares in the last quarter. Murphy Middleton Hinkle & Parker Inc. acquired a new position in shares of AdvanSix in the fourth quarter valued at approximately $702,000. SG Americas Securities LLC increased its position in shares of AdvanSix by 1,145.9% during the fourth quarter. SG Americas Securities LLC now owns 67,812 shares of the company’s stock worth $1,173,000 after acquiring an additional 62,369 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of AdvanSix by 6.4% during the third quarter. JPMorgan Chase & Co. now owns 72,116 shares of the company’s stock worth $1,398,000 after acquiring an additional 4,367 shares in the last quarter. 86.39% of the stock is currently owned by institutional investors.
AdvanSix Company Profile
AdvanSix, Inc (NYSE: ASIX) is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.
The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.